Records containing: Solid Tumor
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2014-01-01A Multicenter Prospective Randomized Study Comparing Non Myeloablative (Flu-TBI) and Reduced Intensity (FLU-BU-ATG) Conditioning in Allogenic Transplantation
-
CLINICAL_TRIALS study record update · 2013-11-14Phase I Clinical Trial of RAD001 in Combination With CP-751,871 in Patients With Advanced Sarcomas and Other Malignant Neoplasms
-
CLINICAL_TRIALS study record update · 2013-11-01A Phase I, Dose-Escalating Study of the Safety of Intravenous CALAA-01 in Adults With Solid Tumors Refractory to Standard-of-Care Therapies
-
CLINICAL_TRIALS study record update · 2013-09-13A Phase I Dose-Escalation Study of IMGN388 in Patients With Solid Tumors
-
CLINICAL_TRIALS study record update · 2013-05-03A Phase 1 Dose Escalation Study of ARQ 736 in Adult Subjects With Advanced Solid Tumors Harboring BRAF and/or NRAS Mutations
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2013-04-02A Pilot Study of Aprepitant Versus Ondansetron for the Treatment of Opioid Induced Nausea and Vomiting
-
CLINICAL_TRIALS study record update · 2013-04-02Opioid Titration In the Hospice Setting: Barriers Assessment and Modification of the Model Order Sheet and Protocol Stage 2, Part B
-
CLINICAL_TRIALS study record update · 2013-03-26Phase 1, Multicenter, Open-Label, Dose-Escalation, Safety, Pharmacodynamic, and Pharmacokinetic Study of PEGPH20 (PEGylated Recombinant Human Hyaluronidase) Given Intravenously to Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2013-03-08A Phase I Study of Subutinib Maleate Capsules on Toleration and Pharmacokinetics
-
CLINICAL_TRIALS study record update · 2013-02-12A Phase I, Open-label, Dose Escalation, Non-randomized Study to Assess the Pharmacokinetics, Dose Limiting Toxicity, and Maximum Tolerated Dose of OPB-31121 in Subjects With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2013-01-29Pilot Study of the Effects of Epidermal Growth Factor Receptor (EGFR) Inhibitors on Magnesium Homeostasis
-
CLINICAL_TRIALS study record update · 2012-12-21Phase I Trial to Compare Pharmacokinetics and Safety of SYP-0704A With Taxotere in Subjects With Advanced Solid Tumor
-
CLINICAL_TRIALS study record update · 2012-11-21An Open Label, Multicenter Phase I Study Of Selective Cyclin Dependent Kinase Inhibitor P1446A-05 In Subjects With Advanced Refractory Malignancies
-
CLINICAL_TRIALS study record update · 2012-11-01Pharmacokinetic Study of CPT-11, Raltegravir and Midazolam With Characterisation of UGT1A1 Genotype
-
CLINICAL_TRIALS study record update · 2012-10-24Opioid Titration in the Hospice Setting: Barriers Assessment and Modification of the Model Order Sheet and Protocol Stage 2, Part A
-
CLINICAL_TRIALS study record update · 2012-09-10Assessment of Family Quality of Life Among Families With a Member Who is a Cancer Patient
-
CLINICAL_TRIALS study record update · 2012-09-06A Phase I, Open-label, Dose-escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Intravenously Administered ATI-1123, a Liposomal Docetaxel Formulation, on an Every 3 Week Schedule, in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2012-09-03Pilot Study of the Effects of Epidermal Growth Factor Receptor (EGFR) Inhibitors on the EGFR in Skin Lesions
-
CLINICAL_TRIALS study record update · 2012-08-16An Open-Label Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of CEP-9722 (a PARP-1 and PARP-2 Inhibitor) as Single-Agent Therapy and as Combination Therapy With Temozolomide in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2012-08-09Phase I Study of Taxotere, Cisplatin, and CPT-11 in Advanced Solid Tumor Malignancies
-
CLINICAL_TRIALS study record update · 2012-08-03(Inhibition of NF-kB Signaling in Melanoma Therapy) A Phase I/II Clinical Trial of PS-341, a Proteasome Inhibitor, in Combination With an Extended Continuous Oral Schedule of Temozolomide in Patients With Advanced Refractory Solid Tumors With the Phase II Component Only in Patients With Melanoma
-
CLINICAL_TRIALS study record update · 2012-07-24A Phase I Study of Tesetaxel Administered in Combination With Capecitabine to Subjects With Solid Tumors
-
CLINICAL_TRIALS study record update · 2012-05-22A Phase 1 Safety and Pharmacokinetic Study of ABT-263 in Combination With Taxotere® (Docetaxel) in the Treatment of Subjects With Solid Tumors
-
CLINICAL_TRIALS study record update · 2012-02-28A Phase I Study of Lithium During Whole Brain Radiotherapy for Patients With Brain Metastases
-
CLINICAL_TRIALS study record update · 2012-02-15A Phase 1b Dose-escalation Study to Evaluate the Safety and Tolerability of the Addition of the Aminopeptidase Inhibitor CHR-2797 to Paclitaxel in Patients With Advanced or Refractory Tumours